Omega Biosystems Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Omega Biosystems General Information

Description

Operator of a global medical technology company intended to develop instruments for drug discovery. The company's technology includes developing cytometry and commercializing disruptive instruments for the cell analysis and drug discovery industries, enabling businesses to commercialize fluorescence imaging optical technology in the field of flow cytometry.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 570 Westwood Plaza
  • Suite 6350
  • Los Angeles, CA 90095
  • United States
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • 570 Westwood Plaza
  • Suite 6350
  • Los Angeles, CA 90095
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omega Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 27-Feb-2017 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
3. Grant 01-Jan-2016 Completed Generating Revenue
2. Grant 31-Dec-2015 $350K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view Omega Biosystems’s complete valuation and funding history, request access »

Omega Biosystems Patents

Omega Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016339956-A1 Multi-modal fluorescence imaging flow cytometry system Active 13-Oct-2015
AU-2016339956-B2 Multi-modal fluorescence imaging flow cytometry system Active 13-Oct-2015
EP-3362778-A1 Multi-modal fluorescence imaging flow cytometry system Active 13-Oct-2015
EP-3362778-B1 Multi-modal fluorescence imaging flow cytometry system Active 13-Oct-2015
JP-2021113811-A Multi-modal fluorescence imaging flow cytometry system Active 13-Oct-2015 G01N15/1434
To view Omega Biosystems’s complete patent history, request access »

Omega Biosystems Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Magnify Accelerator/Incubator
U.S. Department of Health and Human Services Government
UCLA CNSI Incubator Accelerator/Incubator Minority
US National Science Foundation Accelerator/Incubator
To view Omega Biosystems’s complete investors history, request access »

Omega Biosystems FAQs

  • When was Omega Biosystems founded?

    Omega Biosystems was founded in 2014.

  • Where is Omega Biosystems headquartered?

    Omega Biosystems is headquartered in Los Angeles, CA.

  • What industry is Omega Biosystems in?

    Omega Biosystems’s primary industry is Discovery Tools (Healthcare).

  • Is Omega Biosystems a private or public company?

    Omega Biosystems is a Private company.

  • What is Omega Biosystems’s current revenue?

    The current revenue for Omega Biosystems is .

  • Who are Omega Biosystems’s investors?

    Magnify, U.S. Department of Health and Human Services, UCLA CNSI Incubator, and US National Science Foundation have invested in Omega Biosystems.

  • When was Omega Biosystems acquired?

    Omega Biosystems was acquired on 27-Feb-2017.

  • Who acquired Omega Biosystems?

    Omega Biosystems was acquired by BD Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process